A phase I study of different doses and frequencies of pegylated recombinant human granulocyte-colony stimulating factor (PEG rhG-CSF) in patients with standard-dose chemotherapy-induced neutropenia.
Chin J Cancer Res
; 29(5): 402-410, 2017 Oct.
Article
in En
| MEDLINE
| ID: mdl-29142459
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
Language:
En
Journal:
Chin J Cancer Res
Year:
2017
Type:
Article